Items tagged with Treatment
Treatment-decision score for children with HIV and suspected TB (post)
A new treatment-decision score for the diagnosis of tuberculosis (TB) in children with HIV performed well, and when used in an algorithm may facilitate prompt treatment decision making for children at a high risk for mortality, according to data published in Pediatrics.
Dolutegravir-based regimen safe and effective for people taking rifampicin for TB (post)
A study from Botswana published in the October issue of the Journal of Acquired Immune Deficiency Syndromes provides important scientific evidence, but not strong enough data for a policy change, on the use of a dolutegravir-based antiretroviral therapy (ART) regimen along with a rifampicin-based anti-tuberculosis (TB) regimen, for people living with HIV and TB coinfection.
Mylan working on launch of new TB drug in India (post)
Multinational pharmaceutical company Mylan is working with Drug Controller General of India (DCGI) to launch pretomanid, a medicine used to treat drug-resistant TB, said a company top-official.
TB Alliance and Macleods announce commercial partnership for new therapy for highly drug-resistant TB (post)
NEW YORK and MUMBAI (October 28, 2019)—Non-profit drug developer TB Alliance has granted Macleods Pharmaceuticals Limited a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug “BPaL” regimen. Pending regulatory approvals, Macleods has agreed to commercialize the anti-tuberculosis (TB) medicine in approximately 140 countries and territories.
Analysis: South Africa secures good prices for TB medicines, with one exception (post)
An article published in Spotlight compares prices in recent South African Government tender for TB medicines versus global prices available via the Global Drug Facility. The article covers bedaquiline, delamanid, linezolid and rifapentine.
HIV, pregnancy and TB medication: Do they mix? (post)
Tuberculosis disease is a global killer, infecting 10 million people every year and taking the lives of 1.5 million. Being HIV positive is a risk factor for contracting tuberculosis disease and dying from it. Pregnancy also leaves women vulnerable to the ravages of tuberculosis, and pregnant women who also have HIV are especially at risk.
Heated debate on access to TB drugs at global meet (post)
A panel discussion on partnership to treat TB at the 50th Union World Conference on Lung Health ended in a heated debate over unavailability and unaffordability of improved TB drugs in India.
How an AI solution can design new TB drug regimens (post)
ANN ARBOR—With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective treatments.
New treatment to tackle drug-resistant strains of TB could now be possible (post)
New drugs to treat strains of TB which have become resistant to treatment are now a possibility following a ground breaking discovery from the University of Surrey.
Bedaquiline-based treatment associated with favorable outcomes in patients with MDR-TB (post)
Bedaquiline-based regimens for treating patients with multidrug-resistant tuberculosis, MDR-TB, were associated with favorable outcomes and a lower rate of acquired drug resistance compared with delamanid-based regimens, according to a study conducted in the country of Georgia.
Page 50 of 106 · Total posts: 0
←First 49 50 51 Last→